Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06393062 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gram Stain of the First Urine After Puncture in Percutaneous Nephrolithotomy

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 22, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Aug 31, 2024 to Aug 31, 2025
    • Study completion date: Sep 30, 2024 to Sep 30, 2025
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this study, investigators compared the systemic inflammatory responses after percutaneous nephrolithotomy (PCNL) patients who were given an expanded empirical antibiotic regimen based on the prediction of the possibility of bacteria identified by Gram staining the first urine after renal puncture and patients whose antibiotic regimen was not performed and whose antibiotic regimen was adjusted according to patient symptoms and culture results. Investigators aimed to test its diagnostic value in predicting and preventing complications.
Trial Details
NCT Number NCT06393062
Lead Sponsor Adiyaman University
Conditions
(from sponsor)		 Percutaneous Nephrolithotomy
Related terms Fever, Systemic Inflammatory Response Syndrome
Enrollment 245 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov